Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant interactions with warfarin

D Duncan1, K Sayal, H McConnell

  • 1Bethlem and Maudsley NHS Trust, London, UK.

International Clinical Psychopharmacology
|July 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bovine TB infection status in cattle in Great Britain in 2023.

The Veterinary record·2025
Same author

A randomised controlled feasibility trial of a clinical protocol to manage hypotension during major non-cardiac surgery.

Anaesthesia·2023
Same author

Bovine TB infection status in cattle in Great Britain in 2021.

The Veterinary record·2023
Same author

Bovine TB infection status in cattle in Great Britain in 2020.

The Veterinary record·2022
Same author

Bovine TB infection status in cattle in Great Britain in 2019.

The Veterinary record·2021
Same author

The meaning of critical thinking in diagnostic radiography.

Radiography (London, England : 1995)·2021
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Warfarin and antidepressant interactions can alter blood thinning. Citalopram, nefazodone, and sertraline show lower interaction risk, while fluoxetine, fluvoxamine, paroxetine, and moclobemide carry higher risks, requiring careful monitoring.

Area of Science:

  • Pharmacology
  • Drug Interactions
  • Clinical Pharmacy

Background:

  • Warfarin, a common anticoagulant, has a narrow therapeutic index.
  • Antidepressants can significantly alter warfarin's anticoagulant effect through various mechanisms.
  • Understanding these interactions is crucial for patient safety.

Purpose of the Study:

  • To review and synthesize available data on warfarin-antidepressant interactions.
  • To identify specific antidepressants with higher or lower interaction potentials.
  • To provide clinical guidance for managing these drug combinations.

Main Methods:

  • Comprehensive literature search using Medline and hand searches.
  • Contacting pharmaceutical manufacturers for interaction data.

Related Experiment Videos

  • Analysis of interactions based on antidepressant classes and cytochrome P450 pathways.

    • Main Results:

    • Citalopram, nefazodone, and sertraline appear to have a relatively lower potential for warfarin interaction.
    • Fluoxetine, fluvoxamine, paroxetine, and moclobemide exhibit a higher potential for significant interactions.
    • Insufficient data exists to predict venlafaxine's interaction potential.

    Conclusions:

    • Specific antidepressants pose varying risks of altering warfarin's anticoagulant activity.
    • Awareness of these interactions is vital for clinicians prescribing these medications concurrently.
    • Tailored International Normalized Ratio (INR) monitoring strategies are recommended based on the co-prescribed antidepressant.